NYSE · Medical - Diagnostics & Research

Thermo Fisher Scientific Inc (TMO) Stock

$658.02 +0.93% NYSE: TMO Healthcare

Valuation

MetricValue
Price$658.02
Market Cap$243.30B
P/E Ratio36.25
P/B Ratio4.75
P/S Ratio5.39
EPS (TTM)$17.74
52-Week High$691.84
52-Week Low$435.27
Dividend Yield0.28%

Financials & Margins

MetricValue
ROE13.35%
ROA6.17%
ROCE8.49%
Gross Margin18.20%
Operating Margin18.20%
Net Margin15.06%
Debt/Equity0.81
Current Ratio1.89

Annual Financials (USD)

Metric20212022202320242025
Revenue$39.2B$44.9B$42.9B$42.9B$44.6B
Operating Profit$10.3B$8.5B$7.4B$7.7B$8.1B
Net Profit$7.7B$7.0B$6.0B$6.3B$6.7B
EPS$19.46$17.64$15.45$16.53$17.74
Op Margin26.3%19.0%17.4%17.9%18.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$95.1B$97.2B$98.7B$97.3B$110.3B
Total Liabilities$54.1B$53.0B$51.9B$47.6B$56.8B
Cash$4.5B$8.5B$8.1B$4.0B$9.9B
Borrowings$36.3B$36.1B$36.4B$32.8B$39.4B

Latest News

Thermo Fisher Scientific Announces Quarterly Dividend Business Wire · Jul 9, 2026 On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations PR Newswire · Jul 8, 2026 Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG PR Newswire · Jul 8, 2026 Thermo Fisher (TMO) Wins FBI Approval For Rapid DNA Tool In Crime Investigations Simply Wall St. · Jul 7, 2026 Is ICLR Stock a Value Trap or Turnaround After an Earnings Reset? Zacks · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$9.5B$9.2B$8.4B$8.7B$7.8B
Investing Cash Flow$-24.5B$-4.4B$-6.6B$-7.2B$-5.6B
Financing Cash Flow$-1.9B$-3.0B$-2.9B$-3.8B$-2.9B
Net Cash Flow$-5.8B$4.0B$-440.0M$-4.1B$5.8B
Free Cash Flow$7.0B$6.9B$6.9B$7.3B$6.3B

Valuation & Return Ratios

MetricValue
PEG Ratio4.87
EV / EBITDA26.34
FCF Yield2.93%
Quick Ratio1.18
Interest Coverage5.68
Return 1Y21.13%
Return 3Y32.98%
Return 5Y14.14%

Ownership

Insiders Held0.15%
Institutions Held94.03%
Institutions Float Held94.17%
Institutional HolderSharesReport Date
Blackrock Inc.30,427,1922026-03-31
Vanguard Capital Management LLC24,280,8162026-03-31
State Street Corporation16,731,6682026-03-31
Morgan Stanley10,863,5282026-03-31
FMR, LLC10,776,4362026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc is led by CEO Marc N. Casper, employs 125,000 people, headquartered in Waltham, US, publicly traded since 1980.

Thermo Fisher Scientific Inc (TMO) stock trades at $658.02 with a market capitalization of $243.30B. The stock is valued at a price-to-earnings (P/E) ratio of 36.25, price-to-book of 4.75, price-to-sales of 5.39. Over the past 52 weeks the stock has ranged between $435.27 and $691.84, and currently trades 4.9% below its 52-week high. It pays a dividend yielding 0.28%.

On profitability, Thermo Fisher Scientific Inc generates a return on equity (ROE) of 13.35%, above the typical market average, return on capital employed of 8.49%, an operating margin of 18.20%, a net profit margin of 15.06%.

In its most recent fiscal year, Thermo Fisher Scientific Inc reported annual revenue of $44.6B, net profit of $6.7B, revenue has compounded at 6.7% a year over the last five years, profit at 1.1% a year.

The balance sheet shows a debt-to-equity ratio of 0.81, a current ratio of 1.89, total assets of $110.3B, $9.9B in cash and equivalents.

TMO has a beta of 0.85.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20% PFE Pfizer, Inc. $28.28 +1.65%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides